Table 2.

Univariate analysis of clinicopathologic variables (calretinin expression, WT1 expression, histological subtype, therapy intervention, gender and previous cancer diagnosis) for overall survival in MPM patients, expressed as 95% confidence interval (95% Cl) and P-value (log-rank test)

Variables	HR (95% CI)	P
Calretinin	0.24 (0.14–0.42)	< 0.0001***
WT1	0.52 (0.27–1.03)	0.06
Histotype	2.28 (1.51–3.44)	< 0.0001***
Therapeutic intervention	0.47 (0.27–0.82)	0.006**
Gender	0.73 (0.46–1.17)	0.19
Previous cancer	0.88 (0.50–1.54)	0.65

Statistical significance is indicated by asterisk (*), where * = P < 0.05, ** = P < 0.01, *** = P < 0.001